Riteish Deshmukh’s historical drama *Raja Shivaji* continued its steady run at the box office on Day 16, maintaining momentum despite new releases entering cinemas this week. The film, which has drawn attention for its period setting and performance-driven narrative, is now moving closer to the Rs 100 crore mark after more than two weeks in theatres.

Trade movement around the film has remained stable through its third weekend phase, a period often seen as decisive for theatrical endurance. While fresh competition has arrived at the box office, *Raja Shivaji* has managed to retain audience interest, helped by consistent footfall and positive word of mouth surrounding its storytelling approach.

The film has also benefited from appreciation for its performances, with Riteish Deshmukh’s role remaining a major talking point among viewers. Industry observers have noted that historical dramas often depend heavily on sustained audience engagement after the opening week, and *Raja Shivaji* appears to be maintaining that support well into its second week.

Its current trajectory places the film within reach of the Rs 100 crore milestone, a figure that carries symbolic importance for large-scale theatrical releases. Though the pace of earnings has naturally slowed from its initial days, the collections have continued at a level strong enough to keep the film in active contention at the box office.

The film’s theatrical run has unfolded at a time when audience response has become increasingly unpredictable across genres. In that context, *Raja Shivaji* sustaining attention beyond the opening stretch reflects a degree of consistency that many recent releases have struggled to achieve.

Honor Robot Phone Gets Q3 2026 Launch Window as ARRI Partnership Comes Into Focus

For exhibitors and distributors, the coming days are likely to determine how strongly the film closes its theatrical cycle. At present, however, *Raja Shivaji* remains firmly in the conversation, with its box office journey still carrying momentum as it edges toward another commercial benchmark.